Close

Novavax (NVAX) Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/16/2024

1. SPY
2. TSLA
3. JNJ
4. AMD
5. GS
6. ITCI
7. BAC
8. MS
9. BK
10. UNH


Go back to Novavax (NVAX) Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization
Novavax, Inc. (NASDAQ: NVAX) Delayed: 4.03 -0.09 (2.18%)
Previous Close $4.12    52 Week High $9.23 
Open $4.07    52 Week Low $1.16 
Day High $4.11    P/E N/A 
Day Low $3.95    EPS $-0.30 
Volume 3,121,924